Data / Form D filings / SOLARIS PHARMA CORP
SOLARIS PHARMA CORP: Form D filings
SOLARIS PHARMA CORP, a pharmaceuticals company in Bridgewater, NJ, filed 3 Form D notices with the SEC between 2016 and 2020. The latest, on January 31, 2020, reports $10 million sold of a $10 million offering to 6 investors.
Find out what SOLARIS PHARMA CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1031 ROUTE 202-206, SUITE G-200, Bridgewater, NJ, 08807
- Phone
- (908) 864-0404
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- New Jersey
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1689748
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 31, 2020 | New notice | $10,000,000 | $10,000,000 | $0 | 6 | Dec 9, 2019 | sec.gov |
| Aug 13, 2018 | New notice | Indefinite | $0 | Indefinite | 0 | Yet to occur | sec.gov |
| Nov 10, 2016 | New notice | $13,439,997 | $13,439,997 | $0 | 6 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Bernhard Lakshmi Hampl | Director | |
| Srinivas Lakshmi Raghavan | Executive Officer, Director | |
| Manish Lakshmi Potti | Director | |
| Satish Lakshmi Pejaver | Executive Officer, Director | |
| Helmut Lakshmi Jeggle | Director |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Jan 27, 2020 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what SOLARIS PHARMA CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.